tirzepatide once a week Dosing for Weight Loss in Units Effect of once-weekly tirzepatide on

These drugs are administered through subcutaneous injection once a week and mimic the hormones that your body naturally makes that keep your metabolism running properly

These requirements mirror those that may have limited adoption of Rybelsus, the oral semaglutide from Novo Nordisk approved for diabetes in 2019. One challenge in developing oral versions of semaglutide is that the drug is based on chains of amino acids known as peptides which are subject to degradation by enzymes in the stomach. In contrast, Eli Lillys upcoming oral GLP1 candidate, orforglipron, is a smallmolecule drug rather than a peptide, which could lessen the need for dosing requirements and offer greater convenience to users. This ease of use has fueled expectations of growing market share for oral GLP-1 formulations, with analysts estimating they could generate $22 billion annually by 2030, capturing 24% of the global weight loss market. For plan sponsors, the arrival of oral options means usage could grow, reinforcing the need for comprehensive utilization-management strategies

MUC2 plays a role in the development of colorectal cancer, which led Meng et al

28074-1-AP, Lot No

doi: 10.3390/nu15030743 56 FlemingMSanchez-FueyoASafiniaN

Glucose-6-phosphate dehydrogenase deficiency and the inflammatory response to endotoxin and polymicrobial sepsis*